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Effect of "fast track" admission for acute myocardial infarction
on delay to thrombolysis
Alastair C H Pell, Hugh C Miller, Colin E Robertson, Keith A A Fox
Abstract
Objective-To evaluate the impact of a fast track
triage system for patients with acute myocardial
infarction.
Design-Comparison of delays in admission to
hospital and in receiving thrombolytic treatment
before and after introducing fast track system with
delays recorded in 1987-8. Patients fulfiling clinical
and electrocardiographic criteria for myocardial
infarction were selected for rapid access to the
cardiac care team, bypassing evaluation by the
medical registrar.
Setting-Major accident and emergency, cardiac
and trauma centre.
Subjects-359 patients admitted to the cardiac
care unit during 1 February to 31 July 1990 with
suspected acute infarction.
Main outcome measures-Accuracy of diagnosis
and delay from arrival at hospital to thrombolytic
treatment.
Results-248 of the 359 patients had myocardial
infarction confirmed, of whom 127 received throm-
bolytic treatment. The fast track system correctly
identified 79 out of 127 (62%) patients who sub-
sequently required thrombolytic treatment. 95%
(79/83) of patients treated with thrombolysis after
fast track admission had the diagnosis confirmed by
electrocardiography and enzyme analysis. The median
delay from hospital admission to thrombolytic treat-
ment fell from 93 minutes in 1987-8 to 49 minutes in
fast track patients (p<0001). Delay in admission to
the cardiac care unit was reduced by 47% for fast
track patients (median 60 minutes in 1987-8 v 32
minutes in 1990, p<0001) and by 25% for all patients
(60 minutes v 45 minutes, p<0001).
Conclusion-This fast track system requires no
additional staffor equipment, and it halves inhospital
delay to thrombolytic treatment without affecting
the accuracy of diagnosis among patients requiring
thrombolysis.
Introduction
Experimentally and clinically prognosis after acute
myocardial infarction is dependent on the duration of
myocardial ischaemia.'7 Although clinical benefit has
been shown with thrombolysis in patients presenting
more than six hours after onset of symptoms of
myocardial infarction, very early thrombolytic
treatment maximises the functional and survival
benefits.8-'2 Delay in the hospital constitutes an
important and potentially avoidable component of the
total delay. Studies in major cardiac centres in the
United States and Europe report hospital delays of 50-
130 minutes.23' 13-15 Practical triage systems for mini-
mising such delay have not yet been established.
An audit of patients admitted to our hospital in
1987-8 found median delays from arrival to thrombo-
lysis of 93 minutes, and the delay in patients with
unequivocal electrocardiographic evidence of acute
myocardial infarction was no shorter than in patients
with suspected myocardial infarction.'6 A relatively
small proportion of patients (23% of those with in-
farction) received thrombolytic treatment. The audit
identified several factors that contributed to inhospital
delay, including triplication of patient assessment by
accident and emergency staff, the duty medical regis-
trar, and the cardiac care team. The triage system was
common to all medical emergencies and the require-
ment for thrombolysis was assessed only after admission
to cardiac care unit.
Edinburgh Royal Infirmary is the main accident and
emergency and trauma centre for the Lothian region
and in 1990, 68641 new patients were evaluated. A
duty medical registrar received all emergency medical
referrals and was responsible for their initial evalua-
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tion, treatment, and transfer. In 1990, 1243 patients
were admitted to the cardiac care unit and 10755
patients were discharged from acute medical wards.
Thus patients with acute myocardial infarction
patients constituted only one part of the duty medical
registrar's heavy workload.
To minimise each of the components of inhospital
delay we devised and introduced a "fast track" admis-
sion system. In other hospitals a fast track system has
been devised in which patients with infarction
were identified before reaching hospital by para-
medic ambulance staff and staff of the emergency
department.' However, as yet, systems using para-
medic ambulance staff have had limited applicability.
The principles of the Edinburgh fast track system
were: to permit very early identification of patients
with clear cut myocardial infarction; to avoid multiple
assessments of patients and the concomitant delays;
and to permit the cardiac care team to evaluate and
treat patients in the emergency department or the
cardiac care unit.
In the fast track triage system patients are selected
for treatment by the cardiac care team by using
predefined clinical and electrocardiographic criteria,
and routine evaluation by the duty medical registrar is
bypassed. The cardiac care team establishes the diag-
nosis and initiates thrombolytic treatment in the
emergency department or the cardiac care unit. We
evaluated the system's impact in the first six months
after its introduction.
TABLE I-Patients with myocardial infarction confirmed at discharge:
those receiving thrombolytic treatment and those not fulfilling criteria
for treatment during six months in 1987-8'6 and 1990
No (%) of No (%) of
patients 1987-8 patients 1990
(n= 237) (n=248)
Received thrombolysis
No thrombolysis
Reasons for not treating:
Electrocardiogram not diagnostic
Onset of symptoms >6 h previously
Peptic ulcer
Age >70 years
Miscellaneous*
54 (23) 127 (51)
183 (77) 121 (49)
80 (34)
49(21)
7 (3)
20 (8)
27 (11)
56 (23)
22 (9)
6 (2)
0
37 (15)
*Includes traumatic resuscitation, bleeding diathesis, and hypertension.
suspected acute myocardial infarction over the six
months from 1 February to 31 July 1990. Transfers
from other units within the Royal Infirmary or from
other hospitals were excluded from the analysis.
The protocol specified that all patients who clearly
fulfilled the defined clinical and electrocardiographic
criteria for myocardial infarction would be admitted by
the fast track route and the remainder, in whom the
diagnosis was uncertain, would be formally evaluated
by the medical registrar. We compared the results with
those obtained in the 1987-8 audit.'6 In contrast with
the policy in 1987-8 there was no upper age limit to
thrombolytic treatment. The appendix gives the inclu-
sion and exclusion criteria for thrombolytic treatment
during the study. The Mann-Whitney test was used to
determine the significance of differences between
median times.
Subjects and methods
Before the fast track system was implemented we
examined the admission patterns during 1-31 January
1990 to determine whether the patterns had changed
appreciably since the previous detailed audit during
1 August 1987 to 31 January 1988.1'
A simplified protocol for fast track admission of
patients with myocardial infarction (figure) was agreed
with the consultant physicians in the specialty group in
medicine, the junior medical staff, and the emergency
department staff. The protocol was displayed in the
emergency department and junior medical staff were
encouraged to adopt the protocol. After an instruction
phase of about one month, the fast track system was
implemented on 1 February 1990. This report includes
all patients presenting from outside the hospital with
Definite myocardial
infarction
FAST TRACK
* Obtain venous access
* Give analgesia
* Call cardiac care team
Cardiac care team assesses
patient and gives: thrombolytic
treatment if required
Admission to
cardiac care unit
Criteria for fast track
admission
Typical pain or discomfort for
0 5- 6 h plus
Electrocardiogram showing
ST elevation > 1 mm in
leads I, II, III, aVL, aVF
or
ST elevation > 2 mm in
leads V2 - V6
or
Showing a true posterior
myocardial infarction
Fast track admission system for patients with acute myocardial
infarction
Results
Analysis of admissions in the period before the
fast track policy was implemented showed that the
inhospital delays were similar to those during the
1987-8 audit. The median time between arrival at
hospital and admission to the cardiac care unit was 55
minutes and the time to initiation of thrombolytic
treatment was 92 minutes after hospital admission (210
minutes after onset of symptoms; 59 patients, 25
treated with thrombolysis).
Between 1 February and 31 July 1990, 359 patients
were admitted to the cardiac care unit with suspected
acute myocardial infarction. At discharge, 248 (69%)
of these had had myocardial infarction confirmed. In a
further 90 patients (25%) the final diagnosis was
unstable angina, and in 21 (6%) there were other
diagnoses (predominantly atypical chest pain). During
the 1987-8 audit 352 patients had been admitted with
suspected myocardial infarction and a similar propor-
tion (237 (67%)) had had the diagnosis confirmed.
Of the 248 patients with confirmed myocardial
infarction in 1990, 127 (51%) received thrombolytic
treatment. Nine patients in whom acute myocardial
infarction was not confirmed also received thrombo-
lytic treatment. Only 54/237 (23%) patients received
thrombolytic treatment during the previous audit.
Table I shows the numbers of patients with acute
myocardial infarction who did and did not receive
thrombolytic treatment. Failure to meet the electro-
cardiographic criteria or symptoms of more than six
hours' duration were the reasons for non-treatment in
129 (54%) patients with confirmed infarction in 1987-8
and 78 (3 1%) patients in 1990.
ACCURACY OF INITIAL DIAGNOSIS
The 112 patients admitted by the fast track route all
had an initial diagnosis of suspected acute myocardial
infarction. At discharge 96 (86%) had the diagnosis
confirmed, based on electrocardiographic and enzyme
determiinations. Thrombolytic treatment was given to
83 patients, of whom 79 (95%) had myocardial infarc-
tion confirmed by electrocardiographic and enzyme
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criteria (table II). Among the remaining four patients,
one had acute pericarditis diagnosed and in three the
electrocardiograms suggested acute myocardial infarc-
tion with reperfusion (early ST resolution) but a rise in
cardiac enzyme concentrations was not seen (possibly
representing "aborted" infarction).
Of247 patients admitted by the non-fast track route,
53 fulfilled electrocardiographic criteria for acute
myocardial infarction and all 53 received thrombolysis.
Forty eight (910%) of these had a final diagnosis of acute
myocardial infarction. Of the remaining patients
admitted by the non-fast track route, 104 had an
eventual diagnosis of myocardial infarction and 95 had
other diagnoses including angina and non-cardiac
pain. Overall, nine of the 359 patients (four admitted
by fast track system) received thrombolytic treatment
but showed no rise in cardiac enzyme concentrations to
confirm infarction. In none of these nine patients did
the final diagnosis involve another organ system, and
no patient with aortic dissection received thrombolysis.
The apparent false positive rate for thrombolytic
treatment (true positives were defined as patients with
electrocardiographic and enzymic confirmation) was
5% (4/83) for the fast track admissions and 9% (5/53)
for the other admissions. However, the fast track
system aims at selecting patients who clearly meet
electrocardiographic criteria and hence these false
positive rates are not comparable. Furthermore, a rise
in enzyme concentrations is aborted in a few patients
treated very early after the onset of myocardial infarc-
tion, and in some patients sufficient numbers of
enzyme estimations may not have been undertaken
to exclude an increased concentration. Of the 127
patients with acute myocardial infarction eligible for
thrombolytic treatment (based on diagnosis at dis-
charge), 79 (62%) were identified by the emergency
I . rr I I .........-....... I I . 1 .. .r. . Idepartment statl and admitted by the
COMPARISON OF TIME DELAYS BETWEI
AND 1990
Overall, the time from hospital a
ment with thrombolysis was reduce(
93 minutes in 1987-8 to 49 min
admitted by the fast track system an
all patients in 1990 (p<0-001). A;
TABLE II-Confirmed myocardial infarction
ment in patients admitted by the fast track an
durting six months in 1990. Numbers in pareni
Fa
adn
(n
79
17
4
12
Myocardial infarction confirmed
Thrombolysis
No thrombolysis
Myocardial infarction not confirmed
Thrombolvsis
No thrombolvsis
1987-8
All
patients
(a)
Hospital arrival to cardiac care unit
(min)
Time to thrombolytic treatment (min):
After admission to hospital
After onset of symptoms
1990
Fast track Non-fast track All
admissions admissions patients
(h) (c) (d)
60 32 52 45
93 49 73-5 52
177-5 150 217 5 180
*95% Confidence interval for differences in median times.
TABLE IV-Time from amrval at hospital to admission to cardiac care
unit during six months in 1987-8'6 and 1990
Time (minutes)
0-15
-30
-45
-60
-75
-90
-105
-120
-135
>136
No (%) of all No (%) of fast track
patients 1987-8 patients 1990
(n= 352)* (n= 112)
7 (20)
32 (10)
44 (13)
85 (26)
56 (17)
44 (13)
20 (6)
26 (8)
3 (1)
14 (4)
4 (4)
43 (38)
37 (33)
15 (13)
7 (6)
5 (4)
1 (1)
0
0
0
*331 Patients with full information on timing.
system was introduced the time between admission to
hospital and admission to the cardiac care unit was
reduced for the fast track admissions by 47% (60
minutes in 1987-8 v 32 minutes in 1990) and 25% for all
patients (60 minutes v 45 minutes) (table III). Table IV
gives the distribution of delays for all admissions in
1987-8 and for fast track admissions in 1990. Overall,
the median times to admission to the cardiac care unit
and to thrombolytic treatment were significantly
shorter in 1990 compared with 1987-8 (p<0-001 for
both). The fast track route significantly shortened
inhospital delays (p<0-001) and total time to thrombo-
lytic treatment (p<0 001) in comparison with the non-
fast track route. Between 1987-8 and 1990 the delay in
getting to hospital lengthened (79 minutes in 1987-8 v
107 minutes in 1990), and consequently the overall
delay from the onset of symptoms to treatment was not
significantly altered (table III).
Discussion
e fast track system. The fast track system correctly identified nearly two
EN 1987-8 thirds of all the patients who subsequently were shownto have required thrombolytic treatment, and it
reduced inhospital delays to thrombolysis. During theidmission to treat- period of analysis, no patient sustained evidence of
i from a median of embolic or haemorrhagic stroke and no patient requireddutes for patients transfusion for bleeding complications.d to 52 minutes for In the 1987-8 audit we showed that inhospital delays
fter the fast track contributed substantially to the total duration of
ischaemia in patients with acute myocardial infarc-
and thrombolytic treat- tion. 6 A median of 60 minutes elapsed between arrival
theses are percentages in the emergency department and arrival in the cardiac
care unit, with an additional 30 minutes before
vsttrack Non-fast track thrombolytic therapy was started. The fast track
nussions admissions admission system, which required no extra staff or
equipment, has halved the inhospital delay for patients
96 (86) 152 (62) with clear evidence of infarction. Furthermore, in-
104 hospital delays for all patients admitted to the cardiac
16(14) 95(38) care unit with suspected acute myocardial infarction
90 were cut by 25%. In January 1990, immediately before90 the fast track system was introduced, the inhospital
delay was similar to that in 1987-8 despite an active
spected acute myocardial thrombolysis programme and a written policy for
identifying patients for thrombolysis.
In 1987-8 a relatively small proportion of patients
with acute infarction received thrombolytic treatment
(23%) in comparison with half of such patients in 1990.inValuer(9oalc)onfidence The removal of an age restriction for thrombolysis in
the cardiac care unit has contributed to the increase in[a v b<0 00l (25 to 35) thrombolytic treatment and resulted in an older popu-
avd<0 001 (14 to 22) lation distribution (17% of patients aged >70 years in
lbvc<0-00l (2 to 21) 1990 v none in 1987-8). Previous studies have shown[a v b<0001 (35 to 56) that elderly people experience longer delays, especiallyJ avc<0-05 (4 to 33)
as' d<0 001 (26 to 47) before reaching hospital."8
bv c<0001 (16 to 34) The high proportion of patients with confirmed[avh NS (- 16to40)javc<0-05 (-63to-2) myocardial infarction in the cardiac care unit is a
avd NS (-33 to 23) reflection of shortage of intensive care beds rather
[ than an ideal practice (eight beds with an average
occupancy of 73%). The fast track system has not
BMJ VOLUME 304 11 JANUARY 1992
TABLE Itt-Median inhospital delays and delays to thrombolysis in patients with sui
infarction during six months in 1987-8's and 1990
85
increased inappropriate referrals to the cardiac care
unit. For both the fast track and non-fast track routes
over 90% ofpatients admitted with suspected infarction
and given thrombolytic treatment had the diagnosis
confirmed. Although nine patients given thrombolytic
treatment did not show increased enzyme concen-
trations, in none of these did the final diagnosis involve
another organ system. Failure to show increased
enzyme concentrations may also reflect reperfusion
and "aborted" myocardial infarction.
Maintenance of the fast track system requires
coordinated training of cardiac and emergency depart-
ment staff, periodic audit, and the review of data on
all patients delayed more than 15 minutes in the
emergency department. It necessitates 24 hour avail-
ability of the cardiac care team. Our fast track system
has the advantage ofnot requiring all junior emergency
department staff to be familiar with the inclusion and
exclusion criteria for thrombolysis. This is particularly
relevant to those departments that have a high and
regular turnover of junior medical staff. The fast track
system removes patients with clear evidence of infarc-
tion from general medical assessment, and we found no
evidence that the remainder of patients suffered
additional delays. Indeed, patients with ambiguous
features, admitted by the medical registrar, had delays
reduced by 13-3% (table III).
COMPARISON WITH OTHER STUDIES
In North America, inhospital delays of 50 to 130
minutes have been reported in major cardiac centres'3 14
and similar figures have been obtained in Europe and
in Britain.23'5 Among American men entered into a
large study of thrombolysis the median delay to
thrombolysis was 4-9 hours and only a fifth of men
were treated within two hours of onset of symptoms."9
Thus the findings in the 1987-8 audit in Edinburgh
were not atypical for major cardiac centres, although
unacceptable in the era of thrombolysis. In our present
study the median times from onset of symptoms to
thrombolysis were 2- 5 hours for fast track patients and
3-6 hours for other patients.
Would thrombolysis before reaching hospital pro-
vide a feasible alternative for minimising delay? In the
Seattle experience there was a potential time saving of
about 60 minutes, but only 4% of patients with
suspected myocardial infarction were eligible for treat-
ment before arriving at hospital.20 In that study
thrombolysis was administered in hospital, a median of
1-9 hours after onset of symptoms. The large scale
European study (EMIP) is randomising patients before
hospital and inhospital treatment by using mobile
intensive care units staffed by doctors and has reported
a time gain of about 60 minutes when treatment is
given before reaching hospital but a median delay of
2-2 hours from symptom onset (comparable with the
delay with inhospital treatment in our study).2' An
alternative strategy would be direct access to the
cardiac care unit, but this requires sufficient beds to
admit patients to rule out infarction and a suitable
triage area for managing patients with non-cardiac
conditions.22
Our study shows that changes in hospital practice
can substantially reduce the delay to thrombolysis.
Studies of thrombolysis treatment before patients
reach hospital should therefore be compared with
optimal rather than historical inhospital treatment.
Our study was conducted during a period of heavy
clinical demand and restricted bed availability, and the
findings cannot be regarded as reflecting optimal
treatment. Further reductions might be achieved
if thrombolytic treatment could be started in the
emergency department with minimal delay. In our
hospital emergency priorities and availability of space
have restricted the application of thrombolysis in the
emergency department. Bolus administration systems
may obviate this problem.
Although simple in design, the fast track system
necessitated a change in working practice for the
emergency department, the cardiac care unit, five
acute medical receiving units, and the technical and
paramedical staff. The system could not have been
implemented if the senior house officer in the cardiac
care unit had shared responsibility for other aspects of
care. The main time savings achieved with the fast
track system are a consequence of a clear, fully
implemented policy which avoids duplicate assess-
ments and which identifies patients with a high prob-
ability of acute infarction. The fast track system
may be useful in other regional cardiac centres and
district general hospitals.
We thank Dr R A Elton, Department of Public Health
Medicine, for advice and help with statistical analysis.
Appendix
Criteria for thrombolytic treatment were: history consistent
with acute myocardial infarction; ST segment elevation of
>1 mm in limb leads or >2 mm in precordial leads or ST
segment depression in precordial leads consistent with early
posterior myocardial infarction; and onset of symptoms
within six hours.
Specific exclusion criteria included previous history of
cerebral haemorrhage, cerebrovascular accident within past
two months, severe hypertension (diastolic pressure
>120 mm Hg), recent traumatic resuscitation, a history
of gastrointestinal or urinary bleeding within six months,
surgery or head injury within one month, diabetic prolifera-
tive retinopathy, bleeding diathesis, warfarin treatment, and
pregnancy.
Streptokinase was the drug of choice unless it had been
given between five days and one year previously. Under these
conditions alteplase was given.
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Irritable bowel syndrome inthe general population
Roger Jones, Susan Lydeard
Abstract
Objective-To determine the prevalence of
symptoms compatible with a clinical diagnosis of
irritable bowel syndrome in the general population.
Design-Validated postal questionnaire sent to
2280 subjects randomly selected in 10 year age bands
from the lists of eight general practitioners. The
Manning criteria were used to define irritable bowel
syndrome.
Setting-Urban population in Southampton
and mixed urban-rural population in Andover,
Hampshire.
Results-A response of71% yielded 1620 question-
naires for analysis, ofwhich 412 (25%) reported more
than six episodes of abdominal pain in the preceding
year, with 350 (22%) reporting symptoms consistent
with the diagnosis of irritable bowel syndrome. The
male: female ratio was 1:1.38. More subjects with
irritable bowel syndrome had constipation and
diarrhoea and 35% with the syndrome reported
rectal bleeding compared with an overall prevalence
of 20%. Other symptoms and conditions including
heartburn, dyspepsia, flushing, palpitations,
migraine, and urinary symptoms were significantly
more common in the group with irritable bowel
syndrome. Abdominal pain in childhood was more
common in the subjects with irritable bowel syn-
drome (12%) than without (3%). One third of the
group with irritable bowel syndrome had sought
medical advice during the study period (male: female
ratio 1:1.21); consultation behaviour was influenced
by age and the presence of associated symptoms,
varied considerably among patients registered with
different general practitioners, and was poorly
correlated with symptom severity.
Conclusion-Symptoms consistent with a diag-
nosis of irritable bowel syndrome are present in
almost one quarter of the general population and
tend to be associated with a number of other
complaints and conditions, some of which may
reflect smooth muscle dysfunction.
Introduction
The irritable bowel syndrome is the commonest
functional gastrointestinal disorder seen in both
primary and secondary care,'2 and studies have shown
that symptom complexes compatible with the clinical
diagnosis of irritable bowel syndrome may be present
in up to 30% of the general population.34 Most people
with gastrointestinal symptoms never consult doctors
about them5; previous studies on dyspepsia, for
example, have shown that concern about the possible
serious significance ofsymptoms is a major determinant
of consultation behaviour.6 This is likely to be true for
irritable bowel syndrome also.
Traditionally, irritable bowel syndrome has been a
diagnosis of exclusion, made only after organic disease
has been ruled out by investigation. Unnecessary
investigations not only involve costs to the health
services but also may increase diagnostic uncertainty
and heighten patients' anxiety. In an attempt at greater
precision, Manning and his coworkers reported the
prevalence of 15 symptoms in irritable bowel syndrome
and compared these with symptoms in patients with
organic disease.7 They concluded that six cardinal
symptoms discriminated the painful variant of irritable
bowel syndrome from organic bowel disease. The more
of these six symptoms that were present, the more
likely it was that the patients had irritable bowel
syndrome. Subsequently Thompson examined the
discriminatory value of four symptoms-abdominal
pain relieved by defecation, abdominal distension, and
both looser and more frequent bowel movements with
the onset of pain -and concluded that iftwo or more of
these symptoms are present irritable bowel syndrome
could be discriminated from peptic ulcer or organic
bowel disease.8 Talley and colleagues have evaluated
the reliability and discriminatory value of the Manning
criteria in irritable bowel syndrome by using an
objective self report questionnaire.9 Their findings
suggest that these criteria can discriminate subjects
with all forms of the syndrome from healthy controls
and also from patients with organic gastrointestinal
disease, although a recent study has cast some doubt on
the diagnostic utility of the Manning criteria in men.'0
There is also interesting evidence of disease associ-
ations with irritable bowel syndrome. A substantial
number of patients also have abnormalities of bladder
detrusor muscle function," and asssociations with a
variety of urinary and gynaecological symptoms and
with headache have been noted.'2"3 Most recently,
patients with irritable bowel syndrome and without
respiratory symptoms have been shown to have
abnormally responsive airways after methacholine
challenge, compared with normal controls and patients
with organic bowel disease. '4 The possibility that a
generalised smooth muscle abnormality underlies all
these conditions is a subject of considerable research
and potential therapeutic interest.
Irritable bowel symptoms are common in the general
population and in patients with organic disease,'5 and
the predictive value of any criteria will vary according
to the prevalence of the disease in the population being
assessed. Most people with symptoms will not present
for medical care and it is possible that the symptom-
atology of presenting and non-presenting patients is
different.34 Heaton's group, for example, has recently
reported more severe abnormalities of bowel function,
as well as more severe pain, in outpatients with irritable
bowel syndrome compared with subjects with symp-
toms of irritable bowel syndrome identified in a
community survey who had not sought medical
attention.'6 Other reports, however, have suggested
that it is more likely that sociocultural factors, rather
than the type or severity ofsymptoms, lead to differen-
tial health seeking behaviour in those suffering from
irritable bowel syndrome,'7-20 suggesting that the
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